Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04255108 · ClinicalTrials.gov registry record
Validation of a Sensor for Non-invasive Measurement of Stroke Volume and Cardiac Output
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Completed
- Registry status
- 50
- Enrollment target
NCT04255108 is a clinical trial that has completed, run by Baxter Healthcare Corporation. The registered enrollment target is 50 participants.
The verdict
NCT04255108 has completed, sponsored by Baxter Healthcare Corporation.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
toSense, Inc. has developed a novel, non-invasive, body-worn sensor -CoVa Patch-that offers an alternative to invasive continuous cardiac output monitoring. To validate this new sensor's measurements of stroke volume and cardiac output, toSense, Inc. will conduct a study that compares its measurement performance to that from a pulmonary artery catheter using the thermodilution method.
Interventions
- DEVICE Cova Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2020-04-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04255108
The ClinicalTrials.gov registry entry for NCT04255108 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cova Patch is the first listed.
NCT04255108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04255108 about?
NCT04255108 is a clinical study titled "Validation of a Sensor for Non-invasive Measurement of Stroke Volume and Cardiac Output". toSense, Inc. has developed a novel, non-invasive, body-worn sensor -CoVa Patch-that offers an alternative to invasive continuous cardiac output monitoring. To validate this new sensor's measurements of stroke volume and cardiac output, toSense, Inc. will conduct a study that compares its measuremen...
What is the current status of trial NCT04255108?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2020-02-19. Estimated completion is 2020-04-09.
What interventions are being tested in trial NCT04255108?
The interventions under investigation include: Cova Patch (DEVICE).
Who is sponsoring clinical trial NCT04255108?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.